Global Nanomedicine Market, By Product Type (Nano Molecules, Nanoparticle, Liposomes, Polymer and Polymer Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Nanoshells, Nanotubes, Nanodevices), Application (Vaccines, Regenerative Medicines, Diagnostic Imaging, Drug Delivery, Implants, In-Vitro Imaging, In-Vitro Diagnostics, Therapeutics, Others), Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Disorders, Urological Disorders, Ophthalmological Diseases, Immunological Diseases, Anti-Inflammatory Diseases, Anti-Infective Diseases, Others) Modality (Treatments, Diagnostics) – Industry Trends and Forecast to 2030.
Nano Medicine Market Analysis and Size
Major factors that are expected to boost the growth of the nanomedicine market in the forecast period are the advancing technologies for drug delivery. Furthermore, the rise in the acceptance of nanomedicine across diverse applications is further anticipated to propel the growth of the nanomedicine market. Moreover, the increase in government support and funding is further estimated to cushion the growth in the nanomedicine market.
Data Bridge Market Research analyses that the nanomedicine market which was USD 377.37 million in 2022, would rocket up to USD 964.15 million by 2030, and is expected to undergo a CAGR of 12.7% during the forecast period. This indicates that the market value. "Nano Molecules" dominates the type segment of the nanomedicine market due to the high demand for this type of molecule. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Nano Medicine Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Nano Molecules, Nanoparticles, Liposomes, Polymer And Polymer Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Nanoshells, Nanotubes, Nanodevices), Application (Vaccines, Regenerative Medicines, Diagnostic Imaging, Drug Delivery, Implants, In-Vitro Imaging, In-Vitro Diagnostics, Therapeutics, Others), Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Disorders, Urological Disorders, Ophthalmological Diseases, Immunological Diseases, Anti-Inflammatory Diseases, Anti-Infective Diseases, Others) Modality (Treatments, Diagnostics)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Ablynx (Belgium), Arrowhead Pharmaceuticals (U.S.), BIND Therapeutics (U.S.), CytImmune Sciences (U.S.), Elan Corporation (Ireland), Ensysce Biosciences (U.S.), Genzyme Corporation (U.S.), Gilead Sciences (U.S.), Insys Therapeutics (U.S.), Intarcia Therapeutics (U.S.), Nanobiotix (France), Nanoprobes (U.S.), Nanospectra Biosciences (U.S.), Nanosphere Health Sciences (U.S.), Pfizer (U.S.), Stealth BioTherapeutics (U.S.), Starpharma (Australia)
|
|
Market Opportunities
|
|
Market Definition
Nanomedicine is one of the applications of nanotechnology that is utilized in diagnosing, treating, monitoring, and controlling biological systems. Nanomedicine utilizes nanoscale manipulation of materials to augment medicine delivery. Therefore, nanomedicine has enabled the treatment of several diseases. Nanomedicine is in the budding stage, as various products are developing.
Nano Medicine Market Dynamics
Drivers
- Rising Advancing Technologies for Drug Delivery
Growing advancing technologies for drug delivery is among the essential factors intensifying the growth and demand of the nanomedicine market. This, in turn, has carved the way for the market's growth
- Research and Development Proficiencies
Rising expenditure for research and development proficiencies, especially in developed and developing economies, about medical drugs and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical drugs also bolstered the market growth rate
- Growing Investment in Healthcare Facilities
The surging focus on improving healthcare facilitie’s conditions and overall healthcare infrastructure is another important factor fostering market growth. The rising number of partnerships and strategic collaborations between the public and private players about funding and application of new and improved technology further creates lucrative market opportunities
Opportunities
- Growth in the Healthcare Facilities
The rise in the out-licensing of nano drugs and the growth of healthcare facilities in advancing countries upsurge in the public-private funding for target research activities. Rising product innovations and development owing to technological advancements worldwide will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Likewise, the rise in worldwide healthcare expenses will further provide potential opportunities for the growth of the nanomedicine market in the coming years.
Restraints/Challenges
- High Cost Associated with R&D
The lengthy approval process, dangers related to nanomedicine, high cost associated with the research and development proficiencies, limited infrastructural facilities, which are further projected to impede the growth of the nanomedicine market in the timeline period, and absence of awareness in the backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios, technology penetration in the developing economies, and lack of suitable infrastructure in low and middle income countries are projected to challenge the market in the forecast period of 2023 to 2030
This nanomedicine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nanomedicine market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Recent Developments
- In 2020, Pfizer announced that it had developed a new nanomedicine platform that can be used to deliver genetic material to cells in the body. The platform, called Lipid InOrganic Hybrid Nanoparticles (LIONs), has the potential to be used in a wide range of applications, including gene therapy
- In 2019, Roche acquired Spark Therapeutics, a company specializing in gene therapy development. The acquisition gave Roche access to Spark's proprietary gene therapy platform, which uses adeno-associated viruses (AAVs) to deliver therapeutic genes to cells in the body
Global Nanomedicine Market Scope
The nanomedicine market is segmented on the basis of product type, application, indication, and modality. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Nano Molecules
- Nanoparticles
- Liposomes
- Polymer and Polymer Drug Conjugates
- Hydrogel Nanoparticles
- Dendrimers
- Nanoshells
- Nanotubes
- Nanodevices
Application
- Vaccines
- Regenerative Medicines
- Diagnostic Imaging
- Drug Delivery
- Implants
- In-Vitro Imaging
- In-Vitro Diagnostics
- Therapeutics
- Others
Indication
- Oncological Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Orthopedic Disorders
- Neurological Disorders
- Urological Disorders
- Ophthalmological Diseases
- Immunological Diseases
- Anti-Inflammatory Diseases
- Anti-Infective Diseases
- Others
Modality
- Treatment
- Diagnostics
Nanomedicine Market Regional Analysis/Insights
The nanomedicine market is analyzed and market size insights and trends are provided by product type, application, indication, and modality, as referenced above.
The countries covered in the nanomedicine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America is expected to dominate the nanomedicine market because of the strong base of healthcare facilities, the strong presence of major players, and the rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Nanomedicine Market Share Analysis
The nanomedicine market competitive landscape provides details by competitor. details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. the above data points provided are only related to the company's focus related to nanomedicine market.
Some of the major players operating in the nanomedicine market are:
- Ablynx (Belgium)
- Arrowhead Pharmaceuticals (U.S.)
- BIND Therapeutics (U.S.)
- CytImmune Sciences (U.S.)
- Elan Corporation (Ireland)
- Ensysce Biosciences (U.S.)
- Genzyme Corporation (U.S.)
- Gilead Sciences (U.S.)
- Insys Therapeutics (U.S.)
- Intarcia Therapeutics (U.S.)
- Nanobiotix (France)
- Nanoprobes (U.S.)
- Nanospectra Biosciences (U.S.)
- Nanosphere Health Sciences (U.S.)
- Pfizer (U.S.)
- Stealth BioTherapeutics (U.S.)
- Starpharma (Australia)
SKU-